熱門資訊> 正文
Beta Bionics股价下跌，公司将1.5亿美元的股票发行价定为17.25美元/股
2026-09-16 17:43
- Beta Bionics (BBNX) priced an underwritten public offering of 7,652,175 common shares at $17.25/share plus pre-funded warrants for 1,043,484 shares at $17.2499 each.
- Gross proceeds are expected to be about $150.0M before fees and expenses, the company said.
- Closing is expected on or about Sept. 17, 2026.
- The stock fell 7% in early trading on Wedneday.
More on Beta Bionics
- Beta Bionics, Inc. 2026 Q2 - Results - Earnings Call Presentation
- Beta Bionics, Inc. (BBNX) Q2 2026 Earnings Call Transcript
- Beta Bionics: Some Stabilization In Sight
- Beta Bionics plans $125M public offering; shares down
- Beta Bionics outlines Mint launch by end of Q2 2027 while raising 2026 gross margin outlook to 58.5%-59.5%
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
